{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:29:28Z","timestamp":1792783768852,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hubei Provincial Administration of Traditional Chinese Medicine","award":["ZY2023M002"],"award-info":[{"award-number":["ZY2023M002"]}],"id":[{"id":"https:\/\/ror.org\/03x55t826","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Hubei Provincial Administration of Traditional Chinese Medicine","award":["ZY2023M002"],"award-info":[{"award-number":["ZY2023M002"]}],"id":[{"id":"https:\/\/ror.org\/03x55t826","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Hubei Provincial Administration of Traditional Chinese Medicine","award":["ZY2023M002"],"award-info":[{"award-number":["ZY2023M002"]}],"id":[{"id":"https:\/\/ror.org\/03x55t826","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Hubei Provincial Administration of Traditional Chinese Medicine","award":["ZY2023M002"],"award-info":[{"award-number":["ZY2023M002"]}],"id":[{"id":"https:\/\/ror.org\/03x55t826","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Hubei Provincial Administration of Traditional Chinese Medicine","award":["ZY2023M002"],"award-info":[{"award-number":["ZY2023M002"]}],"id":[{"id":"https:\/\/ror.org\/03x55t826","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Hubei Provincial Administration of Traditional Chinese Medicine","award":["ZY2023M002"],"award-info":[{"award-number":["ZY2023M002"]}],"id":[{"id":"https:\/\/ror.org\/03x55t826","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Hubei Provincial Administration of Traditional Chinese Medicine","award":["ZY2023M002"],"award-info":[{"award-number":["ZY2023M002"]}],"id":[{"id":"https:\/\/ror.org\/03x55t826","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Hubei Provincial Natural Science Foundation Innovation and Development Joint Fund Project","award":["2022CFD158"],"award-info":[{"award-number":["2022CFD158"]}]},{"name":"Hubei Provincial Natural Science Foundation Innovation and Development Joint Fund Project","award":["2022CFD158"],"award-info":[{"award-number":["2022CFD158"]}]},{"name":"Hubei Provincial Natural Science Foundation Innovation and Development Joint Fund Project","award":["2022CFD158"],"award-info":[{"award-number":["2022CFD158"]}]},{"name":"Hubei Provincial Natural Science Foundation Innovation and Development Joint Fund Project","award":["2022CFD158"],"award-info":[{"award-number":["2022CFD158"]}]},{"name":"Hubei Provincial Natural Science Foundation Innovation and Development Joint Fund Project","award":["2022CFD158"],"award-info":[{"award-number":["2022CFD158"]}]},{"name":"Hubei Provincial Natural Science Foundation Innovation and Development Joint Fund Project","award":["2022CFD158"],"award-info":[{"award-number":["2022CFD158"]}]},{"name":"Hubei Provincial Natural Science Foundation Innovation and Development Joint Fund Project","award":["2022CFD158"],"award-info":[{"award-number":["2022CFD158"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10863-025-10073-y","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T06:42:23Z","timestamp":1760424143000},"page":"351-364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Astragaloside IV ameliorates cardiomyocyte injury and heart failure through hif\/rho\/rock pathway regulation:\u00a0In vitro and in vivo insights"],"prefix":"10.1007","volume":"57","author":[{"given":"Gang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiufen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"10073_CR1","doi-asserted-by":"publisher","first-page":"884","DOI":"10.5551\/jat.RV17009","volume":"24","author":"H Abe","year":"2017","unstructured":"Abe H, Semba H, Takeda N (2017) The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases. J Atheroscler Thromb 24:884\u2013894","journal-title":"J Atheroscler Thromb"},{"key":"10073_CR2","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1080\/13880209.2017.1299768","volume":"55","author":"S Ahmad","year":"2017","unstructured":"Ahmad S, Panda BP, Kohli K, Fahim M, Dubey K (2017) Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model. Pharm Biol 55:1295\u20131303","journal-title":"Pharm Biol"},{"key":"10073_CR3","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1172\/JCI15496","volume":"111","author":"K Brusselmans","year":"2003","unstructured":"Brusselmans K, Compernolle V, Tjwa M, Wiesener MS, Maxwell PH, Collen D, Carmeliet P (2003) Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. J Clin Invest 111:1519\u20131527","journal-title":"J Clin Invest"},{"key":"10073_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10753-015-0272-4","volume":"39","author":"T Chen","year":"2016","unstructured":"Chen T, Wang R, Jiang W, Wang H, Xu A, Lu G, Ren Y, Xu Y, Song Y, Yong S, Ji H, Ma Z (2016) Protective effect of Astragaloside IV against paraquat-induced lung injury in mice by suppressing Rho signaling. Inflammation 39:483\u2013492","journal-title":"Inflammation"},{"key":"10073_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1159\/000526912","volume":"147","author":"E Christopoulou","year":"2022","unstructured":"Christopoulou E, Liamis G, Naka K, Touloupis P, Gkartzonikas I, Florentin M (2022) Hyponatremia in patients with heart failure beyond the neurohormonal activation associated with reduced cardiac output: a holistic approach. Cardiology 147:507\u2013520","journal-title":"Cardiology"},{"key":"10073_CR6","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1159\/000478626","volume":"42","author":"Z Dong","year":"2017","unstructured":"Dong Z, Zhou J, Zhang Y, Chen Y, Yang Z, Huang G, Chen Y, Yuan Z, Peng Y, Cao T (2017) Astragaloside-IV alleviates heat-induced inflammation by inhibiting endoplasmic reticulum stress and autophagy. Cell Physiol Biochem 42:824\u2013837","journal-title":"Cell Physiol Biochem"},{"key":"10073_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.biopha.2018.03.151","volume":"102","author":"M Feng","year":"2018","unstructured":"Feng M, Li Z, Wang D, Wang F, Wang C, Wang C, Ding F (2018) Microrna-210 aggravates hypoxia-induced injury in cardiomyocyte H9c2 cells by targeting CXCR4. Biomed Pharmacother 102:981\u2013987","journal-title":"Biomed Pharmacother"},{"key":"10073_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.semnephrol.2007.01.012","volume":"27","author":"P Fioretto","year":"2007","unstructured":"Fioretto P, Mauer M (2007) Histopathology of diabetic nephropathy. Semin Nephrol 27:195\u2013207","journal-title":"Semin Nephrol"},{"key":"10073_CR9","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/13543784.2023.2263354","volume":"32","author":"I Forzano","year":"2023","unstructured":"Forzano I, Wilson S, Lombardi A, Jankauskas SS, Kansakar U, Mone P, Varzideh F, Santulli G (2023) SGLT2 inhibitors: an evidence-based update on cardiovascular implications. Expert Opin Investig Drugs 32:839\u2013847","journal-title":"Expert Opin Investig Drugs"},{"key":"10073_CR10","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1159\/000493827","volume":"49","author":"L Gong","year":"2018","unstructured":"Gong L, Chang H, Zhang J, Guo G, Shi J, Xu H (2018) Astragaloside IV protects rat cardiomyocytes from hypoxia-induced injury by down-regulation of miR-23a and miR-92a. Cell Physiol Biochem 49:2240\u20132253","journal-title":"Cell Physiol Biochem"},{"key":"10073_CR11","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.7150\/ijms.103986","volume":"21","author":"Z Guo","year":"2024","unstructured":"Guo Z, Tian Y, Gao J, Zhou B, Zhou X, Chang X, Zhou H (2024) Enhancement of mitochondrial homeostasis: a novel approach to attenuate hypoxic myocardial injury. Int J Med Sci 21:2897\u20132911","journal-title":"Int J Med Sci"},{"key":"10073_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/jcdd10050215","volume":"10","author":"KL Heck-Swain","year":"2023","unstructured":"Heck-Swain KL, Koeppen M (2023) The intriguing role of Hypoxia-Inducible factor in myocardial ischemia and reperfusion: A comprehensive review. J Cardiovasc Dev Disease 10:215","journal-title":"J Cardiovasc Dev Disease"},{"key":"10073_CR13","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-018-03105-2","volume":"9","author":"M Koeppen","year":"2018","unstructured":"Koeppen M, Lee JW, Seo SW, Brodsky KS, Kreth S, Yang IV, Buttrick PM, Eckle T, Eltzschig HK (2018) Hypoxia-inducible factor 2-alpha-dependent induction of Amphiregulin dampens myocardial ischemia-reperfusion injury. Nat Commun 9:816","journal-title":"Nat Commun"},{"key":"10073_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/fcp.12232","volume":"31","author":"L Li","year":"2017","unstructured":"Li L, Hou X, Xu R, Liu C, Tu M (2017) Research review on the pharmacological effects of Astragaloside IV. Fundam Clin Pharmacol 31:17\u201336","journal-title":"Fundam Clin Pharmacol"},{"key":"10073_CR15","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.21037\/atm-21-4080","volume":"9","author":"B Li","year":"2021","unstructured":"Li B, Yu J, Liu P, Zeng T, Zeng X (2021) Astragaloside IV protects cardiomyocytes against hypoxia injury via HIF-1\u03b1 and the JAK2\/STAT3 pathway. Annals Translational Med 9:1435","journal-title":"Annals Translational Med"},{"key":"10073_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114943","volume":"287","author":"X Li","year":"2022","unstructured":"Li X, Liang J, Qin A, Wang T, Liu S, Li W, Yuan C, Qu L, Zou W (2022) Protective effect of di\u2019ao Xinxuekang capsule against doxorubicin-induced chronic cardiotoxicity. J Ethnopharmacol 287:114943","journal-title":"J Ethnopharmacol"},{"key":"10073_CR17","doi-asserted-by":"publisher","first-page":"14929","DOI":"10.1007\/s13277-016-5380-8","volume":"37","author":"Y Lian","year":"2016","unstructured":"Lian Y, Wang J, Feng J, Ding J, Ma Z, Li J, Peng P, De W, Wang K (2016) Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer. Tumour Biology: J Int Soc Oncodevelopmental Biology Med 37:14929\u201314937","journal-title":"Tumour Biology: J Int Soc Oncodevelopmental Biology Med"},{"key":"10073_CR18","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.biopha.2017.09.092","volume":"97","author":"ZH Liu","year":"2018","unstructured":"Liu ZH, Liu HB, Wang J (2018) Astragaloside IV protects against the pathological cardiac hypertrophy in mice. Biomed Pharmacother 97:1468\u20131478","journal-title":"Biomed Pharmacother"},{"key":"10073_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/03007995.2024.2317433","volume":"40","author":"HP Marti","year":"2024","unstructured":"Marti HP, Pav\u00eda L\u00f3pez AA, Schwartzmann P (2024) Safety and tolerability of \u03b2-blockers: importance of cardioselectivity. Curr Med Res Opin 40:55\u201362","journal-title":"Curr Med Res Opin"},{"key":"10073_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0254-6272(13)60189-2","volume":"33","author":"S Ren","year":"2013","unstructured":"Ren S, Zhang H, Mu Y, Sun M, Liu P (2013) Pharmacological effects of Astragaloside IV: a literature review. J Tradit Chin Med 33:413\u2013416","journal-title":"J Tradit Chin Med"},{"key":"10073_CR21","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1210\/en.2010-1166","volume":"152","author":"K Schram","year":"2011","unstructured":"Schram K, Ganguly R, No EK, Fang X, Thong FS, Sweeney G (2011) Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho\/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration. Endocrinology 152:2037\u20132047","journal-title":"Endocrinology"},{"key":"10073_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113533","volume":"143","author":"Z Shangzu","year":"2024","unstructured":"Shangzu Z, Qiyang L, Sichao D, Yutong W, Yangyang L, Yan C, Gengqiang Y, Ting Z, Zhiming M, Fuxian L, Liying Z, Yongqi L (2024) The impact of X-rays on cardiac hydrometabolism and the regulatory role of AS-IV. Int Immunopharmacol 143:113533","journal-title":"Int Immunopharmacol"},{"key":"10073_CR23","volume":"9","author":"NM Sharma","year":"2016","unstructured":"Sharma NM, Cunningham CJ, Zheng H, Liu X, Patel KP (2016) Hypoxia-inducible factor-1\u03b1 mediates increased sympathoexcitation via glutamatergic N-methyl-d-aspartate receptors in the paraventricular nucleus of rats with chronic heart failure. Circulation: Heart Failure 9:e003423","journal-title":"Circulation: Heart Failure"},{"key":"10073_CR24","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/aps.2017.208","volume":"39","author":"MT Song","year":"2018","unstructured":"Song MT, Ruan J, Zhang RY, Deng J, Ma ZQ, Ma SP (2018) Astragaloside IV ameliorates neuroinflammation-induced depressive-like behaviors in mice via the PPARgamma\/NF-kappaB\/NLRP3 inflammasome axis. Acta Pharmacol Sin 39:1559\u20131570","journal-title":"Acta Pharmacol Sin"},{"key":"10073_CR25","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/med.21785","volume":"41","author":"HF Su","year":"2021","unstructured":"Su HF, Shaker S, Kuang Y, Zhang M, Ye M, Qiao X (2021) Phytochemistry and cardiovascular protective effects of Huang-qi (Astragali radix). Med Res Rev 41:1999\u20132038","journal-title":"Med Res Rev"},{"key":"10073_CR26","doi-asserted-by":"publisher","first-page":"155798832413107","DOI":"10.1177\/15579883241310763","volume":"19","author":"L Sun","year":"2025","unstructured":"Sun L, Huang N, Yang C, Feng J, Chen H, Feng W, Gao Z, Wang B, Wang J (2025) Hirudin-Based treatment of Diabetes-Induced erectile dysfunction through inhibition of the HIF-1\u03b1 to regulate rhoa\/rock signaling pathway: an in vivo animal experiment. Am J Men\u2019s Health 19:15579883241310763","journal-title":"Am J Men\u2019s Health"},{"key":"10073_CR27","doi-asserted-by":"publisher","first-page":"C728","DOI":"10.1152\/ajpcell.00257.2024","volume":"327","author":"D Tang","year":"2024","unstructured":"Tang D, Gu Y, Chen S, Niu T, Zhu J, Liu P, Ding M, Guo Y (2024) Alpha-ketoglutarate is required for chronic hypoxia-induced cardiac remodeling. Am J Physiol Cell Physiol 327:C728\u2013c36","journal-title":"Am J Physiol Cell Physiol"},{"key":"10073_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jep.2016.05.062","volume":"191","author":"H Tian","year":"2016","unstructured":"Tian H, Lu J, He H, Zhang L, Dong Y, Yao H, Feng W, Wang S (2016) The effect of astragalus as an adjuvant treatment in type 2 diabetes mellitus: A (preliminary) meta-analysis. J Ethnopharmacol 191:206\u2013215","journal-title":"J Ethnopharmacol"},{"key":"10073_CR29","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/s42003-025-07753-1","volume":"8","author":"K Ullah","year":"2025","unstructured":"Ullah K, Ai L, Li Y, Liu L, Zhang Q, Pan K, Humayun Z, Piao L, Sitikov A, Zhao Q, Su Q, Sharp W, Fang Y, Wu D, Liao JK, Wu R (2025) ARNT-dependent HIF-2\u03b1 signaling protects cardiac microvascular barrier integrity and heart function post-myocardial infarction. Commun Biology 8:440","journal-title":"Commun Biology"},{"key":"10073_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/ejhf.1366","volume":"21","author":"AA Voors","year":"2019","unstructured":"Voors AA, Kremer D, Geven C, Ter Maaten JM, Struck J, Bergmann A, Pickkers P, Metra M, Mebazaa A, D\u00fcngen HD, Butler J (2019) Adrenomedullin in heart failure: pathophysiology and therapeutic application. Eur J Heart Fail 21:163\u2013171","journal-title":"Eur J Heart Fail"},{"key":"10073_CR31","doi-asserted-by":"publisher","first-page":"8424326","DOI":"10.1155\/2017\/8424326","volume":"2017","author":"HL Wang","year":"2017","unstructured":"Wang HL, Zhou QH, Xu MB, Zhou XL, Zheng GQ (2017) Astragaloside IV for Experimental Focal Cerebral Ischemia: Preclinical Evidence and Possible Mechanisms. Oxid Med Cell Longev 2017:8424326","journal-title":"Oxid Med Cell Longev"},{"key":"10073_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.905547","volume":"13","author":"B Wang","year":"2022","unstructured":"Wang B, Wang Y, Tan Y, Guo J, Chen H, Wu PY, Wang X, Zhang H (2022) Assessment of fasudil on contrast-associated acute kidney injury using multiparametric renal MRI. Front Pharmacol 13:905547","journal-title":"Front Pharmacol"},{"key":"10073_CR33","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1161\/CIRCRESAHA.112.264473","volume":"110","author":"B Wojciak-Stothard","year":"2012","unstructured":"Wojciak-Stothard B, Zhao L, Oliver E, Dubois O, Wu Y, Kardassis D, Vasilaki E, Huang M, Mitchell JA, Harrington LS, Prendergast GC, Wilkins MR (2012) Role of RhoB in the regulation of pulmonary endothelial and smooth muscle cell responses to hypoxia. Circ Res 110:1423\u20131434","journal-title":"Circ Res"},{"key":"10073_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/FJC.0000000000001380","volume":"81","author":"Y Xie","year":"2023","unstructured":"Xie Y, Wei Y, Li D, Pu J, Ding H, Zhang X (2023) Mechanisms of SGLT2 inhibitors in heart failure and their clinical value. J Cardiovasc Pharmacol 81:4\u201314","journal-title":"J Cardiovasc Pharmacol"},{"key":"10073_CR35","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jpha.2021.05.001","volume":"11","author":"X Xu","year":"2021","unstructured":"Xu X, Xu H, Shang Y, Zhu R, Hong X, Song Z, Yang Z (2021) Development of the general chapters of the Chinese pharmacopoeia 2020 edition: a review. J Pharm Anal 11:398\u2013404","journal-title":"J Pharm Anal"},{"key":"10073_CR36","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1248\/bpb.b18-00854","volume":"42","author":"P Yang","year":"2019","unstructured":"Yang P, Zhou Y, Xia Q, Yao L, Chang X (2019) Astragaloside IV regulates the PI3K\/Akt\/HO-1 signaling pathway and inhibits H9c2 cardiomyocyte injury induced by hypoxia-reoxygenation. Biol Pharm Bull 42:721\u2013727","journal-title":"Biol Pharm Bull"},{"key":"10073_CR37","doi-asserted-by":"publisher","first-page":"e22410","DOI":"10.1096\/fj.202200243R","volume":"36","author":"Z Yang","year":"2022","unstructured":"Yang Z, Li T, Xian J, Chen J, Huang Y, Zhang Q, Lin X, Lu H, Lin Y (2022) SGLT2 inhibitor Dapagliflozin attenuates cardiac fibrosis and inflammation by reverting the HIF-2\u03b1 signaling pathway in arrhythmogenic cardiomyopathy. FASEB Journal: Official Publication Federation Am Soc Experimental Biology 36:e22410","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"key":"10073_CR38","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41401-018-0082-y","volume":"40","author":"B Yin","year":"2019","unstructured":"Yin B, Hou XW, Lu ML (2019) Astragaloside IV attenuates myocardial ischemia\/reperfusion injury in rats via inhibition of calcium-sensing receptor-mediated apoptotic signaling pathways. Acta Pharmacol Sin 40:599\u2013607","journal-title":"Acta Pharmacol Sin"},{"key":"10073_CR39","first-page":"4700","volume":"42","author":"LZ You","year":"2017","unstructured":"You LZ, Lin YX, Fang ZH, Shen GM, Zhao JD, Wang TT (2017) Research advances on astragaloside-IV in treatment of diabetes mellitus and its complications pharmacological effects. Zhongguo Zhong Yao Za Zhi 42:4700\u20134706","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10073_CR40","doi-asserted-by":"publisher","first-page":"600561","DOI":"10.3389\/fphar.2020.600561","volume":"11","author":"Y Yuan","year":"2020","unstructured":"Yuan Y, Fan S, Shu L, Huang W, Xie L, Bi C, Yu H, Wang Y, Li Y (2020) Exploration the mechanism of Doxorubicin-induced heart failure in rats by integration of proteomics and metabolomics data. Front Pharmacol 11:600561","journal-title":"Front Pharmacol"},{"key":"10073_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.tips.2010.12.006","volume":"32","author":"Q Z","year":"2011","unstructured":"Z Q, G C, k L J (2011) Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease. Trends Pharmacol Sci 32:167\u2013173","journal-title":"Trends Pharmacol Sci"},{"key":"10073_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110012","volume":"126","author":"Y Zang","year":"2020","unstructured":"Zang Y, Wan J, Zhang Z, Huang S, Liu X, Zhang W (2020) An updated role of Astragaloside IV in heart failure. Biomed Pharmacother 126:110012","journal-title":"Biomed Pharmacother"},{"key":"10073_CR43","doi-asserted-by":"publisher","first-page":"24900","DOI":"10.1038\/srep24900","volume":"6","author":"Y Zeng","year":"2016","unstructured":"Zeng Y, Zhang X, Kang K, Chen J, Wu Z, Huang J, Lu W, Chen Y, Zhang J, Wang Z, Zhai Y, Qu J, Ramchandran R, Raj JU, Wang J, Gou D (2016) Microrna-223 attenuates hypoxia-induced vascular remodeling by targeting RhoB\/MLC2 in pulmonary arterial smooth muscle cells. Sci Rep 6:24900","journal-title":"Sci Rep"},{"key":"10073_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008369.pub2","author":"HW Zhang","year":"2014","unstructured":"Zhang HW, Lin ZX, Xu C, Leung C, Chan LS (2014) Astragalus (a traditional Chinese medicine) for treating chronic kidney disease. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD008369.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"10073_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20102418","volume":"20","author":"J Zhang","year":"2019","unstructured":"Zhang J, Qiu W, Ma J, Wang Y, Hu Z, Long K, Wang X, Jin L, Tang Q, Tang G, Zhu L, Li X, Shuai S, Li M (2019) miR-27a-5p attenuates Hypoxia-induced rat cardiomyocyte injury by inhibiting Atg7. Int J Mol Sci 20:2418","journal-title":"Int J Mol Sci"},{"key":"10073_CR46","doi-asserted-by":"publisher","first-page":"101777","DOI":"10.1016\/j.redox.2020.101777","volume":"38","author":"H Zhu","year":"2021","unstructured":"Zhu H, Tan Y, Du W, Li Y, Toan S, Mui D, Tian F, Zhou H (2021) Phosphoglycerate mutase 5 exacerbates cardiac ischemia-reperfusion injury through disrupting mitochondrial quality control. Redox Biol 38:101777","journal-title":"Redox Biol"}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-025-10073-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10863-025-10073-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-025-10073-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:02:08Z","timestamp":1770188528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10863-025-10073-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10073"],"URL":"https:\/\/doi.org\/10.1007\/s10863-025-10073-y","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Ethics Committee of Hubei Provincial Hospital of Traditional Chinese Medicine (HDSZYY-2020-01305). All methods were carried out in accordance with relevant guidelines and regulations. All methods are reported in accordance with ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}]}}